Last SFr.246.50 CHF
Change Today +0.60 / 0.24%
Volume 46.3K
STMN On Other Exchanges
Symbol
Exchange
OTC US
Munich
SIX Swiss Ex
OTC US
As of 11:43 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

straumann holding ag-reg (STMN) Snapshot

Open
SFr.245.80
Previous Close
SFr.245.90
Day High
SFr.249.50
Day Low
SFr.243.80
52 Week High
12/8/14 - SFr.257.00
52 Week Low
12/23/13 - SFr.160.10
Market Cap
3.9B
Average Volume 10 Days
45.0K
EPS TTM
SFr.7.49
Shares Outstanding
15.7M
EX-Date
04/15/14
P/E TM
32.9x
Dividend
SFr.3.75
Dividend Yield
1.52%
Current Stock Chart for STRAUMANN HOLDING AG-REG (STMN)

Related News

No related news articles were found.

straumann holding ag-reg (STMN) Related Businessweek News

No Related Businessweek News Found

straumann holding ag-reg (STMN) Details

Straumann Holding AG, through its subsidiaries, is engaged in the research, development, and manufacture of dental implants, instruments, prosthetics, and tissue regeneration products for use in tooth replacement and restoration solutions, or to prevent tooth loss. The company offers replacement solutions, including soft tissue level and bone level implants; SLActive bone formation surface; and Roxolid implants used to replace individual teeth, carry multi-unit bridges, and to attach fixed or removable full dentures. It also provides prosthetic solutions comprising , including one-step restorations, customized abutments, screw-retained bridges and bars, copings, and bridge frameworks, as well as contour crowns and bridges. In addition, the company offers regenerative products, such as Emdogain, which promotes the regeneration of damaged periodontal tissue; BoneCeramic, a synthetic bone substitutes for the formation of new vital bone; Allograft, a bone allograft material; and MembraGel, a generation membrane for use in guided bone regeneration for use to help restore gums, periodontal ligaments, and bone, as well as provides training and education services in cooperation with the International Team for Implantology. It serves general dentists, oral surgeons, periodontists, prosthodontists, and dental technicians/laboratories in approximately 70 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

2,278 Employees
Last Reported Date: 08/26/14
Founded in 1954

straumann holding ag-reg (STMN) Top Compensated Officers

Chief Executive Officer and Member of Executi...
Total Annual Compensation: SFr.1.6M
Compensation as of Fiscal Year 2013.

straumann holding ag-reg (STMN) Key Developments

Straumann Holding AG Announces Revenue Results for the Third Quarter of 2014; Revises Revenue Guidance for the Full Year of 2014

Straumann Holding AG announced revenue results for the third quarter of 2014. Revenue in the third quarter jumped to CHF 164.3 million from CHF 155.2 million a year earlier. Revenues in Europe amounted to CHF 80.8 million, compared with CHF 79.7 million a year ealrier. Revenues in North America rose to CHF 47.7 million, from CHF 43.1 million in the third quarter of 2013, while sales in the Asia/Pacific region climbed to CHF 27.1 million, compared with CHF 23.9 a year earlier. The company raised its full-year guidance, after its revenue rose by 7% in the third quarter. The company now expects revenue growth in the mid-single-digit percentage range, compared with the previous projection for growth in the lower single-digit percentage range.

Straumann Holding AG Announces Executive Changes

Straumann Holding AG announced that After seven years in Switzerland and three years as Straumann's Chief Financial Officer, Thomas Dressendörfer has decided to leave the company in order to be closer to his family in Germany. He will continue at Straumann until June 2015 to support the transition to the new CFO. Thomas Dressendörfer will be succeeded by Dr. Peter Hackel, who will join Straumann on 1 December 2014. Peter Hackel is current CFO of Oerlikon Drive Systems. Peter Hackel joined Oerlikon in 2011 as Head of Group Controlling. Dr. Sandro Matter, Executive Vice President Instradent Management & Strategic Alliances, is also leaving Straumann, having served as a Member of the Executive Management since 2002.

Straumann Holding AG Announces Revenue Results for the First Nine Months of 2014

Straumann Holding AG announced revenue results for the first nine months of 2014. For the nine months, revenue was CHF 523.4 million against CHF 510.0 million a year ago. The performance was driven by gains across all regions particularly in the US, China and Japan. Revenues in Europe amounted to CHF 278.3 million compared with CHF 275.6 million a year ago. Revenues in North America were CHF 139.9 million compared CHF 135.7 million a year ago. Revenues in Asia /Pacific was CHF 78.1 million compared CHF 73.4 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STMN:SW SFr.246.50 CHF +0.60

STMN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $53.70 USD -0.40
Zimmer Holdings Inc $114.91 USD -0.03
View Industry Companies
 

Industry Analysis

STMN

Industry Average

Valuation STMN Industry Range
Price/Earnings 30.1x
Price/Sales 5.1x
Price/Book 5.2x
Price/Cash Flow 30.0x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STRAUMANN HOLDING AG-REG, please visit www.straumann.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.